AI Stock Picks — NASDAQ 100

Thursday, November 12, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Neutral  Normal choppiness · VIX 18.7

The NASDAQ 100 is showing a sharp rotation: mega-cap AI/semiconductor and software leaders (NVDA, META, MSFT, GOOGL, PANW, CRWD) are deep in 30-day drawdowns and well off 52-week highs, while consumer staples, healthcare, and select industrials have quietly pushed to within a few percent of their highs on steady month-long uptrends. A handful of beaten-down semiconductor/memory names are staging sharp 5-day bounces off oversold levels, offering tactical but higher-risk setups.

Rotation out of high-growth AI/semiconductor and software names into defensive staples, healthcare, and industrials near 52-week highsSharp oversold bounce in memory and semicap-equipment names after steep 30-day declines, though most remain far below their highsResilient consumer staples, healthcare majors, and travel/leisure names grinding to fresh highs with consistent multi-week momentumBroad weakness in mega-cap tech (NVDA, META, MSFT, GOOGL) continuing to pressure index-level sentiment

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 2
0%
96 · 279.9%
279.9% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 VRTX SKIP — $542.62 → $569.78
stop $499.21
Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#2 AVGO SKIP — $364.36 → $382.76
stop $329.02
Half-Kelly sizes this at 0% — the odds carry no edge worth capital.

Already open: UNH (to Nov 14), ULVR.L (to Nov 18), PFE (to Nov 19), ROST (to Nov 19), CSX (to Nov 21), TRV (to Nov 22), SGE.L (to Nov 25), SVT.L (to Nov 25), NSC (to Nov 26), RTX (to Nov 27), SO (to Nov 27), CNA.L (to Nov 27) … and 84 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
3 picks
Blaze
6 picks
Nova
2 picks
Orion
1 pick
Quinn
5 picks

2 Stock Picks

Diversification filter applied: 1 pick removed due to high same-sector price correlation with a higher-ranked pick (TXN), avoiding concentrated sector exposure.
#1 VRTXVertex Pharmaceuticals Incorporated
5/5 Agents Agree  Risk 5/10  ⚠ Conflicting Signals
Moderate conviction · 59%

Vertex Pharmaceuticals develops medicines for cystic fibrosis and other serious diseases. The stock has climbed steadily over the past month and is beating the broader tech market by a wide margin, with healthy (not overheated) technical readings supporting more room to run. The main risk is that biotech stocks can swing hard on regulatory or clinical news, and the CEO recently sold a chunk of shares.

Stop-loss$499.21-8.0%
Today's price$542.62
Target$569.78+5.0%
Agents estimate: $569.80 (+0.0% vs target)
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$920 if the stop-loss is hit (-8.0%)
The AI puts the chance of the win case at 59%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • The bull thesis double-counts: the 30-day +11.83% return and the ~19pt relative strength figure are cited as two separate catalysts when they're the same data point restated.
  • Price is already near the upper Bollinger Band (566.92 vs. current 542.62 and a 533.90 midline), leaving limited technical room before mean-reversion resistance kicks in despite the 'not overbought' RSI framing.
  • No GoldenCross is flagged despite price being above both the 50- and 200-day SMAs, and recent 5-day momentum has stalled to just 0.04% after the earlier +11.83% move, suggesting the rally's thrust has already faded.
Show the detailed analysis

Calibrated probability: 59% (raw model estimate: 63%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
61%
+0.2%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
68%
High
Nova
53%
Medium
Orion
61%
High
Quinn
60%
Medium
#2 AVGOBroadcom Inc.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 59%

Broadcom makes chips and software used in networking and, increasingly, custom AI processors for big cloud companies. Its most recent results showed AI-chip revenue more than tripling year-over-year with management guiding for even faster growth ahead, though that report is now a couple of months old and the stock has pulled back sharply from its highs. The main risk is that Broadcom reports its next quarterly results in early December, right in the middle of the holding period, which could cause a big price swing in either direction.

Stop-loss$329.02-9.7%
Today's price$364.36
Target$382.76+5.1%
Agents estimate: $382.94 (+0.0% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$903 if the stop-loss is hit (-9.7%)
The AI puts the chance of the win case at 59%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Stock remains below its own 50-day SMA trend context is muddled: the 200-day SMA (367.34) sits above the 50-day SMA (345.59), a bearish SMA order that contradicts the bullish 'above both MAs' framing often used for momentum picks, and current price (364.36) is still under the 200-day SMA.
  • The 25% five-day bounce is occurring while the stock is still 26% below its 52-week high — this could reflect a dead-cat bounce off oversold lows rather than a genuine re-rating, especially since the 30-day return is a much more modest 1.97%, implying most of the month was spent falling before the recent spike.
  • MACD line remains negative (-3.65) even though the histogram is positive, meaning the 'confirmed upward momentum' is really just a narrowing of a still-bearish MACD posture, not a confirmed bullish crossover into positive territory.
Show the detailed analysis

Calibrated probability: 59% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.

Trade math

0.5:1
66%
-0.3%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
70%
High
Blaze
72%
Very High
Nova
56%
Medium
Orion
—
—
Semiconductor sector is not aligned with the current defensive rotation, and the stock remains over 26% below its 52-week high despite a recent bounce
Quinn
60%
Medium

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by December 12, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by December 12, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 101 NASDAQ 100 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • COSTCostco Wholesale CorporationAlready held
    Scout: Trading within 1% of its 52-week high with a steady +14% 30-day gain and continued +2.5% over the last 5 days — a low-volatility compounder still in an uptrend.
    Already held: a position opened 2026-11-10 runs until 2026-12-10 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ADPAutomatic Data Processing, Inc.Already held
    Scout: Within 1.3% of its 52-week high after an +11.6% 30-day run, showing a durable, low-drama uptrend typical of defensive outperformers.
    Already held: a position opened 2026-11-09 runs until 2026-12-09 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • MARMarriott International, Inc.Already held
    Scout: Just 2% off its 52-week high with a +14.3% 30-day advance and still climbing over the past 5 days — travel/leisure momentum intact.
    Already held: a position opened 2026-11-06 runs until 2026-12-06 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CSXCSX CorporationAlready held
    Scout: Within 2.2% of its 52-week high, up nearly 10% over 30 days with continued positive momentum in the last 5 days.
    Already held: a position opened 2026-10-22 runs until 2026-11-21 (9 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CCEPCoca-Cola Europacific Partners PLCAlready held
    Scout: Trading close to its 52-week high after an +11% 30-day climb, reflecting steady staples demand even as growth tech wobbles.
    Already held: a position opened 2026-11-09 runs until 2026-12-09 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CTASCintas CorporationAlready held
    Scout: Within 2.5% of its 52-week high on a consistent +10% 30-day trend, a classic low-beta grinder likely to extend modestly higher.
    Already held: a position opened 2026-11-11 runs until 2026-12-11 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • FASTFastenal CompanyAlready held
    Scout: Near its 52-week high with accelerating momentum — 5-day gain outpacing the 30-day pace, suggesting the uptrend is strengthening.
    Already held: a position opened 2026-11-11 runs until 2026-12-11 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • XELXcel Energy Inc.Already held
    Scout: Within 3% of its 52-week high; utilities with data-center power exposure continue a steady, uninterrupted climb.
    Already held: a position opened 2026-11-03 runs until 2026-12-03 (21 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • REGNRegeneron Pharmaceuticals, Inc.Already held
    Scout: Only 4% off its 52-week high after a strong +26% 30-day run that is still accelerating (+5.4% over the last 5 days).
    Already held: a position opened 2026-11-11 runs until 2026-12-11 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • VRTXVertex Pharmaceuticals IncorporatedPicked #1
    Scout: Close to its 52-week high with an +11.8% 30-day gain, showing resilient healthcare momentum amid broader tech volatility.
    Made the final report at #1.
  • GILDGilead Sciences, Inc.Already held
    Scout: Within 5% of its 52-week high on a steady +13.5% 30-day advance, a defensive healthcare name still trending up.
    Already held: a position opened 2026-10-30 runs until 2026-11-29 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AMGNAmgen Inc.Already held
    Scout: Trading near its 52-week high after a +13% 30-day run, reinforcing the rotation into defensive biopharma.
    Already held: a position opened 2026-10-29 runs until 2026-11-28 (16 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • SBUXStarbucks CorporationAlready held
    Scout: Within 4% of its 52-week high on a +16.6% 30-day advance, suggesting an ongoing turnaround narrative with real price follow-through.
    Already held: a position opened 2026-11-06 runs until 2026-12-06 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ROPRoper Technologies, Inc.Already held
    Scout: Only 5.8% off its 52-week high after the strongest 30-day gain in its peer group (+29.7%), even with a mild pullback in the last 5 days.
    Already held: a position opened 2026-11-10 runs until 2026-12-10 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • IDXXIDEXX Laboratories, Inc.Already held
    Scout: One of the strongest trends in the index — +34% over 30 days and still rising, within 9% of its 52-week high.
    Already held: a position opened 2026-11-09 runs until 2026-12-09 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • TXNTexas Instruments IncorporatedDiversification filter
    Scout: Accelerating momentum with a +12.3% 5-day pop on top of a +8.6% 30-day gain, now within 6.5% of its 52-week high.
    Dropped by diversification filter: 0.87 30-day daily-return correlation with AVGO (both in Technology).
  • AMZNAmazon.com, Inc.Already held
    Scout: A steady, lower-volatility mega-cap holding up relatively well — up modestly over 5 and 30 days and within 7% of its 52-week high while index peers slide.
    Already held: a position opened 2026-11-04 runs until 2026-12-04 (22 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ABNBAirbnb, Inc.Already held
    Scout: Positive and accelerating momentum (+6.5% over 5 days on top of a +9.4% 30-day gain), within 8.5% of its 52-week high.
    Already held: a position opened 2026-11-06 runs until 2026-12-06 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • GEHCGE HealthCare Technologies Inc.Already held
    Scout: Strong +19% 30-day trend keeping it within 9% of its 52-week high despite a minor recent pullback.
    Already held: a position opened 2026-11-06 runs until 2026-12-06 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • WMTWalmart Inc.Already held
    Scout: Solid +12.4% 30-day gain and within 6.6% of its 52-week high, benefiting from the same defensive-rotation flows as other staples.
    Already held: a position opened 2026-11-02 runs until 2026-12-02 (21 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AMDAdvanced Micro Devices, Inc.Dropped at merge
    Scout: Explosive +44.7% 5-day bounce has pulled it back to within 11% of its 52-week high despite a still-negative 30-day return — the sharpest reversal in the semiconductor group.
    Reward-to-risk 0.43 is below the 0.50 minimum — a +5.02% target against a -11.8% stop.
  • AVGOBroadcom Inc.Picked #2
    Scout: A +25% 5-day rebound with 30-day returns back in positive territory signals the AI-semiconductor selloff may be stabilizing for the sector leader.
    Made the final report at #2.
  • ADIAnalog Devices, Inc.Dropped at merge
    Scout: Only 8% off its 52-week high with a +13.4% 5-day surge, one of the least-damaged names in the semiconductor recovery.
    Only Blaze selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 69% raw (59% after calibration)).
  • MPWRMonolithic Power Systems, Inc.Dropped at merge
    Scout: Both 5-day (+28%) and 30-day (+9.7%) returns are positive, a rare combination among chip names suggesting a genuine trend resumption rather than just a dead-cat bounce.
    Reward-to-risk 0.43 is below the 0.50 minimum — a +5.00% target against a -11.6% stop.
  • NXPINXP Semiconductors N.V.Already held
    Scout: 30-day return of +18% alongside a +9.4% 5-day gain shows sustained strength, not just a one-day spike, within the semiconductor recovery group.
    Already held: a position opened 2026-10-29 runs until 2026-11-28 (16 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.